Table 2.
Differences of the proportions of statistically significant attenuations (positive values) and amplifications (negative values) for the three groups at each ROI
| ROI | Anti | Pro | Fix |
|---|---|---|---|
| SEF | 0.16 | −0.01 | −0.01 |
| FEF | 0.19 | 0.04 | −0.01 |
| SPL | 0.11 | 0.06 | −0.07 |
| Cuneus | 0.09 | −0.03 | −0.07 |
| Thalamus | 0.04 | 0.03 | −0.09 |
| IPL | −0.03 | 0.00 | −0.14 |
| PFC—L | −0.04 | 0.07 | 0.00 |
| PFC—R | 0.04 | −0.01 | −0.01 |
| Striatum | 0.06 | 0.04 | −0.01 |
| MOG | −0.01 | −0.01 | 0.01 |
| IFC | 0.01 | 0.03 | 0.00 |
These values are calculated as: [(proportion of time points attenuated (i.e., number of time points significantly decreased at post‐test) − proportion of time points amplified (i.e., number of time points significantly increased at post‐test))/70]. Values greater than or equal to 0.07 are boldfaced. [SEF (Talairach x = 0, y = 1, z = 56); FEF (LH −34, 5, 53; RH 34, 7, 52); SPL (LH −22, −59, 55; RH 15, −60, 55); cuneus (LH −14, −79, 7; RH 10, −78, 7); thalamus (LH −13, −13, 12; RH 10, −13, 14); IPL (LH −47, −31, 25; RH 54, −42, 23); PFC (LH −34, 34, 38; RH 36, 43, 26); striatum (LH −18, 1, 17; RH 15, 2, 18); MOG (LH −29, −85, 4; RH 24, −87, 4); and IFC (RH 37, 32, 1)].